Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis.
Kostik MM, Isupova EA, Belozerov K, Likhacheva TS, Suspitsin EN, Raupov R, Masalova VV, Chikova IA, Dubko MF, Kalashnikova OV, Chasnyk VG, Cron RQ. Kostik MM, et al. Among authors: suspitsin en. Front Pediatr. 2022 Jul 28;10:894846. doi: 10.3389/fped.2022.894846. eCollection 2022. Front Pediatr. 2022. PMID: 35967555 Free PMC article.
Next generation sequencing analysis of consecutive Russian patients with clinical suspicion of inborn errors of immunity.
Suspitsin EN, Guseva MN, Kostik MM, Sokolenko AP, Skripchenko NV, Levina AS, Goleva OV, Dubko MF, Tumakova AV, Makhova MA, Lyazina LV, Bizin IV, Sokolova NE, Gabrusskaya TV, Ditkovskaya LV, Kozlova OP, Vahliarskaya SS, Kondratenko IV, Imyanitov EN. Suspitsin EN, et al. Clin Genet. 2020 Sep;98(3):231-239. doi: 10.1111/cge.13789. Epub 2020 Jun 17. Clin Genet. 2020. PMID: 32441320
The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience.
Kostik MM, Raupov RK, Suspitsin EN, Isupova EA, Gaidar EV, Gabrusskaya TV, Kaneva MA, Snegireva LS, Likhacheva TS, Miulkidzhan RS, Kosmin AV, Tumakova AV, Masalova VV, Dubko MF, Kalashnikova OV, Aksentijevich I, Chasnyk VG. Kostik MM, et al. Among authors: suspitsin en. Front Pediatr. 2022 Feb 8;10:820586. doi: 10.3389/fped.2022.820586. eCollection 2022. Front Pediatr. 2022. PMID: 35211430 Free PMC article.
Rituximab Biosimilar BCD020 Shows Superior Efficacy above Conventional Non-Biologics Treatment in Pediatric Lupus Nephritis: The Data of Retrospective Cohort Study.
Kostik M, Kalashnikova E, Rinat R, Isupova E, Gaidar E, Soloviev AA, Masalova V, Snegireva L, Kornishina T, Abramova N, Suspitsin E, Sorokina L, Kaneva M, Dubko MF, Lubimova N, Kuchuinskaya E, Kalashnikova O, Chasnyk V. Kostik M, et al. Biomedicines. 2023 May 22;11(5):1503. doi: 10.3390/biomedicines11051503. Biomedicines. 2023. PMID: 37239173 Free PMC article.
IFIH1 and DDX58 gene variants in pediatric rheumatic diseases.
Raupov R, Suspitsin E, Belozerov K, Gabrusskaya T, Kostik M. Raupov R, et al. World J Clin Pediatr. 2023 Jun 9;12(3):107-114. doi: 10.5409/wjcp.v12.i3.107. eCollection 2023 Jun 9. World J Clin Pediatr. 2023. PMID: 37342449 Free PMC article.
Safety and efficacy of canakinumab treatment for undifferentiated autoinflammatory diseases: the data of a retrospective cohort two-centered study.
Alexeeva E, Shingarova M, Dvoryakovskaya T, Lomakina O, Fetisova A, Isaeva K, Chomakhidze A, Chibisova K, Krekhova E, Kozodaeva A, Savostyanov K, Pushkov A, Zhanin I, Demyanov D, Suspitsin E, Belozerov K, Kostik M. Alexeeva E, et al. Front Med (Lausanne). 2023 Nov 15;10:1257045. doi: 10.3389/fmed.2023.1257045. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38034538 Free PMC article.
61 results